The immuno-oncology assays market comprises products that detect biomarkers in specific cancers to enable targeted treatment selection and monitoring of patient responses to immunotherapies. Immuno-oncology assays aid physicians in assessing tumor mutation burden, PD-L1 expression levels, and the presence of other biomarkers that help determine appropriate treatment protocols for cancer...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian